For payers, claims for rare disease treatments used to be uncommon. Not now with an increasing number of new, high-priced ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...

Nirvana, a healthcare technology startup, uses artificial intelligence to better predict insurance coverage. When Kelvin Chan ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A study found that while patients with atopic dermatitis often turn to social media for skincare advice, their decisions are ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Agents that target NaV1.8, a voltage-gated sodium channel, are showing promise. The FDA approved one of them, Journavx ...

Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Kathi Henson, senior vice president of patient services, nursing and quality at Orsini, spoke with MHE editors at this year’s ...